Public Health Institute’s Post

This new study's models revealed concerning findings for both men and women, showing increases in thyroid, kidney, rectal, and colon cancers and leukemia. Specifically for women, there were rises in uterine, pancreatic, and ovarian cancers, along with non-Hodgkin lymphoma. For men, the study projected an increase in prostate cancer. These results highlight the importance of ongoing research and awareness in combating these health challenges. #CancerAwareness #CancerResearch

Interesting news stories today... "Cancer deaths declining overall, but troubling increase for colon and breast cancer in younger adults" followed by "Americans Are Sick for More of Their Lives" "Your Healthspan Is as Important as Your Lifespan—and It’s Declining" It seems that there is more treatment needed than just treating the condition. Perhaps we need to be talking more about lifestyle factors too. Me, I need to work on stress management... https://lnkd.in/gWvBcggq https://lnkd.in/gZJ4wYtd #healthspan #oncology #cancer #passionforpatients

A new cancer study, published in the JAMA Network Open, shows a rise in younger people diagnosed with cancer - particularily those in their 30's. While health experts are not sure what the exact cause is for this rise, they suspect a few reasons could be behind the trend. Here are some of the key findings from the research. 👩🔬🧫🧬 ❓ Why do you think more people under 50 are being diagnosed with cancer? We would love to know your thoughts! 👇 #Cancer CNN

The #BreastCancer Index is a #genomictest (a test that analyze a person’s cancer genes). #Genetictesting is done on a sample of your blood, saliva, or other tissue and can tell if you have a mutation in a gene that is linked to a higher risk of developing breast cancer. The Breast Cancer Index evaluates the activity of 11 genes to help predict the behavior of early-stage, hormone-receptor-positive breast cancer, particularly the likelihood of the disease recurring within 5 to 10 years after diagnosis. Consequently, the test can help women and their doctors decide if extending #hormonaltherapy for 5 more years (10 years total) would be beneficial. Since many women have difficulty tolerating the side effects (e.g., #hotflashes and joint pain) from hormonal therapy, they want to know if extending the duration of hormonal therapy is warranted. https://lnkd.in/euG3Ccvu #cancerresearch

Childhood cancer happens everywhere. Each year, more than 17,000 children are diagnosed with cancer in the United States. Globally, it is estimated that 400,000+ new cases of cancer affect children each year; however, this number may be vastly underestimated due to large numbers of undiagnosed cases. The role of anaplastic lymphoma kinase in pediatric cancers: "ALK is known to be involved in the pathogenesis of neuroblastoma through activating mutations or gene amplification, its role in the pathogenesis of other pediatric cancers is still elusive. In addition to neuroblastoma, the high‐grade amplification of ALK has been described in a subset of rhabdomyosarcoma cases. Normal ALK protein expression is restricted to the nervous systems of adult mammals, but the aberrant expression of ALK has been observed in a variety of pediatric cancers, including glioma and Ewing sarcoma. The discovery of oncogenic activation of ALK in neuroblastoma suggests that this cancer could be potentially treated with an ALK inhibitor, as could other cancers, such as non‐small‐cell lung cancer and anaplastic large‐cell lymphoma." https://lnkd.in/eX5Er_gM We have two stories of ALK+ cancer in children on our website, both very tough reads. The more medical research that we can fund into ALK+ cancer the more it will help everyone. https://lnkd.in/eXKqE2BA #ChildhoodCancerDay #ChildrenWithALK #TogetherWeCan #MoreResearchMoreLife #StrongerTogether #ResearchSavesLives #ALKCancer #ALKPositive #ALKCancerResearch

Social deprivation should be the governments biggest priority: so sad to read yet another report that highlights that women diagnosed with breast cancer in deprived regions are more likely to get a second non-related cancer. Great work by University of Cambridge for highlighting this, now for some policies to help address it..... https://lnkd.in/ebm5Jn3F #socialdeprivation #healthinequalities

The Knotty Ribbon problem of Prostate Carcinoma There is a concerning trend of increase in incidence of prostatic carcinoma that should not be ignored. Dubbed ‘the silent killer’, prostate cancer claimed 397,430 lives globally in 2022, according to the Global Cancer Observatory. A report published in The Lancet on April 4 revealed an even more unsettling projection: prostate cancer is set to escalate global morbidity and mortality. By 2040, cases are anticipated to double, the medical journal said. Worse, with a 30% nationwide surge and an annual influx of 42,000 new cases, India is expected to be among the worst affected countries in the world. Already, the numbers are staggering, with urban areas recording a 75%–80% spike in cases of prostate cancer over the last two-and-a-half decades. The primary reason for late-stage detection is the lack of awareness and early screening. The ribbon problem Have you noticed the light-blue ribbons that pop up every year around September? Those are meant to spread awareness about prostate cancer. However, the problem is that ribbons of various colours have become ubiquitous as the easiest medium for those trying to increase awareness about everything from road safety to climate change, not just cancers. Tracing back the ribbon takes us to Evelyn H Lauder, the Austrian American businessperson and philanthropist who was diagnosed with breast cancer in 1989. She embarked on a mission as an advocate for women’s health. Lauder initiated the groundbreaking pink ribbon campaign within Estée Lauder Companies. They distributed ribbons and self-exam instruction cards at Estée Lauder counters worldwide, sparking conversations, and raising awareness about breast health. Lauder founded the Breast Cancer Research Foundation, raising over USD350 million for global research, education, and medical services. Through this one initiative, breast cancer was brought to the forefront of public consciousness. Since then, the narrative surrounding breast cancer has undergone a profound transformation. Once a stigmatised disease dealt with quietly and in isolation, it has now emerged as a pressing public health issue worthy of widespread discussion and action. Mimicking the success of the breast cancer campaign isn’t merely about changing the hue of the ribbon. The pink ribbon campaign worked because it carried a clear message aimed at solving a specific problem for a well-defined audience. While learning from the success of the breast cancer campaigns is critical, it is also important to note that the messaging should be based on the need of the specific problem at hand. Instead, today ribbons have become the shorthand for cancer campaigns. Simply put, cancer has a big ribbon problem. Citation: https://lnkd.in/gU-y2xNu #prostatecancer #cancer #cancerawareness

Cancer rates in 25 to 49-year-olds increased by 24% between 1995 and 2019 and, while we are getting closer to understanding why, the reasons remain mysterious. I was diagnosed with early-onset colorectal cancer (EOCRC) in summer 2012, at age 25. Despite all the support available, my diagnosis at a young age was very unusual, and it felt incredibly lonely. I was delighted to read today that research into early-onset cancers is picking up pace, with team PROSPECT, funded by Cancer Research UK among others, looking specifically at EOCRC. Current research is focusing on a number of factors: diet, exercise, environmental and societal factors, and features of the microbiome among them. One thing is clear though - since the 1950s, changes have taken place which have led to an increase in early-onset cancers. My tumour was large by the time it was found, but I was incredibly lucky - it had not spread, and I lived in one of the best areas for treatment in the UK. Over a two-year period I received chemoradiotherapy, IV chemo, resection surgery, and further chemo. This brought about early menopause - an extremely difficult process to deal with, but a small price to pay in the scheme of things. It’s natural to want to know why this has happened, and I’m sure every person fighting or surviving cancer has asked that question. In my case, I may never know. Cancer is present in both sides of my family, but no genetic markers have been identified. I’ve realised that answering that question isn’t really important for me on a personal level. The important thing is to know that cancer can happen to anyone and that, whatever symptoms you are experiencing, you must seek advice. Straight away. Even if it’s embarrassing, and even if you are young. This isn’t what I thought I’d be posting on LinkedIn today … but if it helps one person to find the courage to go to their GP, it’s been worth it. The one thing I needed in 2012 was to speak to people my age who were experiencing what I was. I’m so happy to see this research being done and coverage in the press. Cancer Research UK: https://lnkd.in/eXPX2F7E Team PROSPECT: https://lnkd.in/erKnCXRw BBC Inside Health: https://lnkd.in/eSkpepsz 💜 If you can, please give generously to help cancer research and support charities. Cancer Research UK (CRUK): https://lnkd.in/et4aWXsc Macmillan Cancer Support: https://lnkd.in/ebDzYQ45 Bowel Cancer UK: https://lnkd.in/eKSrpt9i #cancer #cancerresearch #bowelcancer #health #research #oncology

Navigation is key!

This article provides the estimated numbers of new cancer cases and deaths in 2024 in the United States nationally and for each state, as well as a comprehensive overview of cancer occurrence based on up-to-date population-based data for cancer incidence and mortality through 2020 and 2021. #oncology #precisionmedicine #cancer #incidence #unitedstates https://lnkd.in/eeWkN-BV